News

News about Indicia Biotechnology

May 2010 : Biomarker quantification at the femtogram level

Indicia Biotechnology and Singulex (USA) collaborates to provide ultrasensitive and early biomarker detection through Erenna® Immunoassay System (more information on our Biomarker Detection page).

September 2009 : Gliadys project

In collaboration with IDD Biotech, Indicia launches a new project, based on therapeutic antibodies against different glioma forms.

June 2009 : Septick shock project

In collaboration with the Lyon's hospitals, and supported by the regional organisation OSEO, Indicia launches a new project to develop an assay to adjust treatments for people with septic shock.

2009 : Indicia is a member of SFRL

This union of in vitro diagnostic industries is a trade association with more than 80 french companies involved in in vitro diagnostic activities.

2009 : Indicia is a member of the biocluster LyonBiopôle

Competitiveness cluster centered on infectious deseases.

Indicia Biotechnology is extending its production facilities

28th March 2008, Indicia has acquired Axcell Biotechnology company.

Thanks to this strategic operation, Indicia Biotechnology strengthens its commercial offer with OEM production services.

The company is now involved in the manufacturing of two products family:

- sterile reagents for IVD and life science companies,
- microbiology culture medias for industrial control.

This new production platform is governed by international standards ISO13485, ISO 9001:2000. We also meet GMP guidelines if required.

For more information, please contact Mr Stéphane LEGASTELOIS slegastelois@indicia.fr